Shiri Habib-Valdhorn On Thursday, August 13th, 2015

Mylan Might Make Do With Only 50% of Perrigo

  Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) deal from 80% to 50%. This means that under More...

Shiri Habib-Valdhorn On Monday, July 27th, 2015

Three Way Takeover Battle – The End: Teva Losing $300 Million on Mylan Stake

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has officially announced that it is withdrawing its bid to buy generic pharmaceuticals rival Mylan N.V. after agreeing to buy Allergan Generics More...

Check Point
Shiri Habib-Valdhorn On Thursday, July 23rd, 2015

Gil Shwed: We Are Up Against Organized Crime

In recent years, awareness has grown for the need for protection against cyber attacks as reflected by well-publicized attacks against major companies and government bodies. Only this week two Israeli hackers More...

Shiri Habib-Valdhorn On Wednesday, July 1st, 2015

Teva CEO: The Industry Is Undergoing a Shakeup

“Size is important in the industry, but it isn’t everything. It’s important to be better. You have to make acquisitions that will suit the company’s strategic direction and contribute More...

Shiri Habib-Valdhorn On Sunday, June 28th, 2015

Are Plus500’s Regulatory Troubles Over?

Has Plus500 put its regulatory troubles behind it? Sources inform “Globes” that it is believed in London that the renewed examination of the company’s customer verification documentation has More...

Shiri Habib-Valdhorn On Thursday, June 18th, 2015

Three Way Takeover Battle: Teva’s Mylan Stake Up to 4.3%

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) continues to accumulate shares in takeover target Mylan (MYL), even as Mylan’s largest shareholder, Abbott Labs (NYSE: ABT), announced More...

(L-R) Robert J Coury, Mylan and Joseph Papa, Perrigo
Shiri Habib-Valdhorn On Thursday, June 18th, 2015

Three Way Takeover Battle: Mylan to List on TASE if Perrigo Bid Succeeds

  One of the main worries of Tel Aviv Stock Exchange (TASE) leaders recently has been the expected delisting of Perrigo Company (NYSE:PRGO; TASE:PRGO), if and when the company’s acquisition by Mylan More...

Shiri Habib-Valdhorn On Monday, June 15th, 2015

Three Way Takeover Battle: Statistics Weigh Against Teva’s Mylan Bid Succeeding

  Will drug company Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) succeed in its attempted hostile takeover of rival Mylan (MYL), or will it be Mylan that succeeds in its own hostile takeover More...

Shiri Habib-Valdhorn On Sunday, May 17th, 2015

Infinity Fund to Hold $100 Million Stake in Baozun After IPO

  Chinese-Israeli fund Infinity Private Equity is on to a very good thing. At the end of last week, Chinese company Baozun filed a revised prospectus for a Nasdaq IPO. The company is seeking a company value More...

Shiri Habib-Valdhorn On Thursday, May 14th, 2015

Three Way Takeover Battle- Teva: We Can Close Mylan Deal in 2015

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) CFO Eyal Desheh remains upbeat about Teva’s attempts to buy Mylan N.V. (Nasdaq: MYL). At the same time, Mylan continues to oppose the takeover More...


Delivered by FeedBurner